Society for Translational Oncology Inc

“Martin and Ann Murphy are husband and wife and both serve as Directors on the Board.”

“The Society is comprised of Members. The primary qualification for membership is to be an Oncologist or otherwise professionally involved with oncology.”

“The completed Form 990 is reviewed by the Chairman and Treasurer of the Board of Directors. After this review, proposed changes are discussed with our tax accountant. If no changes are necessary, copies of the 990 are shared with the full Board and voted upon prior to filing.”

“Conflict of interest disclosures are reviewed annually in accordance with the conflict of interest policy.”

“The Society currently makes its Form 990, organizational documents, and conflict of interest policy available for public inspection upon request.”

“Global Mission The Society for Translational Oncology (STO), a 501(c)(3) not-for-profit organization, is dedicated to advancing global oncology and improving patient care by bridging the gap between scientific discovery and clinical application. Our mission is to promote high-quality, equitable healthcare through innovative education and collaborative global efforts. STO empowers healthcare professionals with the knowledge and tools to implement cutting-edge cancer therapies and improve patient outcomes worldwide. Through strategic guidance and global alliances, we work to harmonize cancer clinical trials and regulatory standards, ensuring that life-saving treatments are speedily accessible to all patients with cancer. Continuing Medical Education Mission STO is committed to providing impactful education to oncology physicians, with the goal of improving the quality and safety of care for patients with cancer. This mission will be fulfilled by offering relevant and effective continuing medical education programs, focusing on: Knowledge and strategies for implementation of critical new developments in cancer treatment, screening, and prevention, the translational gap between research, discovery and delivery of care to the patient, providing content that is evidence-based and within the discipline of clinical medicine, and educational activities that are relevant and impact the practice of physicians within an oncology team in collaboration with nurses, pharmacists and other oncology healthcare professionals.”

“Other Program Consultants: Program service expenses 79,295. Management and general expenses 0. Fundraising expenses 0. Total expenses 79,295. Staffing Contractors: Program service expenses 43,319. Management and general expenses 93,522. Fundraising expenses 0. Total expenses 136,841. Other Consultants: Program service expenses 0. Management and general expenses 22,745. Fundraising expenses 0. Total expenses 22,745.”